{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:07:19Z","timestamp":1760731639696,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000074","name":"U.S. Department of Justice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007236","name":"Office of Justice Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005289","name":"National Institute of Justice","doi-asserted-by":"publisher","award":["15PNIJ-22-GG-04434-MUMU"],"award-info":[{"award-number":["15PNIJ-22-GG-04434-MUMU"]}],"id":[{"id":"10.13039\/100005289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jpba.2024.116254","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T07:24:31Z","timestamp":1716449071000},"page":"116254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Identification of ADB-5\u2019Br-BINACA in plant material and analytical characterization using GC-MS, LC-QTOF-MS, NMR and ATR-FTIR"],"prefix":"10.1016","volume":"247","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-4599","authenticated-orcid":false,"given":"Eduardo G.","family":"de Campos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-1882","authenticated-orcid":false,"given":"Alex J.","family":"Krotulski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116254_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/dta.2935","article-title":"The next generation of synthetic cannabinoids: detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA","volume":"13","author":"Krotulski","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116254_bib2","unstructured":"R.M. Schelkun, D.M. Iula, Laboratory Guide for Synthetic Cannabinoid Identification and Naming, 2022."},{"key":"10.1016\/j.jpba.2024.116254_bib3","unstructured":"U.S. Drug Enforcement Administration, National Forensic Laboratory Information System: NFLIS-Drug 2022 Midyear Report, 2023."},{"key":"10.1016\/j.jpba.2024.116254_bib4","unstructured":"A.J. Krotulski, S.E. Walton, A.L.A. Mohr, B.K. Logan, Synthetic Cannabinoids in the United States \u2013 Trend Report Q2 2023, 2023."},{"key":"10.1016\/j.jpba.2024.116254_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/dta.3609","article-title":"Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists","author":"Norman","year":"2023","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116254_bib6","article-title":"United Nations Office on Drugs and Crime: recommended methods for the identification and analysis of synthetic cannabinoid receptor agonists in seized materials","volume":"3","author":"Tettey","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116254_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/1556-4029.12932","article-title":"Rapid identification of synthetic cannabinoids in herbal incenses with DART-MS and NMR","volume":"61","author":"Marino","year":"2016","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jpba.2024.116254_bib8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/1556-4029.14101","article-title":"4F-MDMB-BINACA: a new synthetic cannabinoid widely implicated in forensic casework","volume":"64","author":"Krotulski","year":"2019","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jpba.2024.116254_bib9","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00216-021-03199-6","article-title":"Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures","volume":"413","author":"Alves","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116254_bib10","unstructured":"Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG), SWGDRUG Recommendations Edition 8.1, 2022. \u3008https:\/\/www.swgdrug.org\/Documents\/SWGDRUG%20Recommendations%20Version%208.1_FINAL_ForPosting_Rev%201-23-23.pdf\u3009 (Accessed 14 April 2024)."},{"key":"10.1016\/j.jpba.2024.116254_bib11","unstructured":"American Standards Board, ANSI\/ASB Standard 036, Standard Practices for Method Validation in Forensic Toxicology, 2019, pp. 1\u201346. \u3008http:\/\/www.asbstandardsboard.org\/wp-content\/uploads\/2019\/11\/036_Std_e1.pdf\u3009 (Accessed 27 January 2022)."},{"key":"10.1016\/j.jpba.2024.116254_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.talanta.2017.02.026","article-title":"Identification and determination of synthetic cannabinoids in herbal products by dry film attenuated total reflectance-infrared spectroscopy","volume":"167","author":"de la Asunci\u00f3n-Nadal","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.116254_bib13","unstructured":"Drug Enforcement and Administration (DEA), Controlled Substance Schedules (last updated on July 7, 2023), 2023. \u3008https:\/\/www.deadiversion.usdoj.gov\/schedules\/orangebook\/c_cs_alpha.pdf\u3009 (Accessed 17 July 2023)."},{"key":"10.1016\/j.jpba.2024.116254_bib14","unstructured":"A.J. Krotulski, J. Shinefeld, R.M. Schelkun, D.M. Iula, M.F. Fogarty, J. DeBord, B.K. Logan, ADB-5\u2019Br-BINACA, 2022. \u3008https:\/\/www.cfsre.org\/nps-discovery\/monographs\/adb-5%E2%80%99br-binaca\u3009 (Accessed 17 July 2023)."},{"key":"10.1016\/j.jpba.2024.116254_bib15","unstructured":"World Health Organization (WHO), Critical Review Report: ADB-BUTINACA, 2022. \u3008https:\/\/cdn.who.int\/media\/docs\/default-source\/controlled-substances\/45th-ecdd\/adb-butinaca_draft.pdf?sfvrsn=89c83ba5_1\u3009 (Accessed 17 July 2023)."},{"key":"10.1016\/j.jpba.2024.116254_bib16","unstructured":"Scientific Instrument Services, Exact Mass Calculator, Single Isotope Version, 2023. \u3008https:\/\/www.sisweb.com\/referenc\/tools\/exactmass.htm#1\u3009 (Accessed 17 July 2023)."},{"year":"1991","series-title":"Spectrometric Identification of Organic Compounds","author":"Silverstein","key":"10.1016\/j.jpba.2024.116254_bib17"},{"year":"2012","series-title":"Introdu\u00e7\u00e3o \u00e0 Espectroscopia (Tradu\u00e7\u00e3o da 4a edi\u00e7\u00e3o norte-americana)","author":"Pavia","key":"10.1016\/j.jpba.2024.116254_bib18"},{"key":"10.1016\/j.jpba.2024.116254_bib19","doi-asserted-by":"crossref","first-page":"9242","DOI":"10.1021\/ac502346h","article-title":"13C NMR metabolomics: applications at natural abundance","volume":"86","author":"Clendinen","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116254_bib20","unstructured":"Slovenian National Forensic Laboratory (NFL), ANALYTICAL REPORT: ADB-BUTINACA (C18H26N4O2) - 2-[(1-butyl-1H-indazol-3-yl)formamido]-3,3-dimethylbutanamide, 2019. \u3008https:\/\/www.policija.si\/apps\/nfl_response_web\/0_Analytical_Reports_final\/ADB-BUTINACA-ID-2082_report.pdf\u3009 (Accessed 19 July 2023)."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T06:38:39Z","timestamp":1720593519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":20,"alternative-id":["S0731708524002942"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116254","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of ADB-5\u2019Br-BINACA in plant material and analytical characterization using GC-MS, LC-QTOF-MS, NMR and ATR-FTIR","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116254"}}